Amarantus BioScience (Seller)Avant Diagnostics (Buyer)
Avant acquiring the Amarantus Diagnostics subsidiary of Amarantus BioScience in a stock deal that values the subsidiary at $25.6 million.
DioGenix (Seller)Amarantus BioScience (Buyer)
Amarantus acquired neuro-diagnostic company DioGenix in a stock deal valued at $8 million
Set Email Alert